# Codex Review: medical_monitoring_profile_point_inspector_20260806

Date: 2026-08-06 (Asia/Shanghai)
Delegated-agent output: none; Codex performed the bounded change and final review directly.

## Verdict

PASS for the bounded offline Patient Profile trend-point inspector slice;
not runtime, clinical, browser/UAT or commercial-release approval.

## Boundary Check

- The changed product scope is limited to
  `MedicalMonitoringSubjectViews.jsx`, its feature CSS and the declared static
  contract; `frontend/dist` is only the derived Vite output.
- No backend/API/service/database/runtime/SQLite/CAS/B6/C14, App ownership,
  Safety/PV, medical-writing, provider, browser, Playwright, API-login or real
  project surface was changed.
- No delegated agent was dispatched.

## Codex Verification

- Local PRD/manual review confirmed the contract requires click-through raw
  facts, with source body before locator-level detail.
- `.venv/bin/python -m pytest -q tests/test_frontend_monitoring_contract.py`:
  **51 passed**.
- `node --test frontend/src/features/medical-monitoring/*.test.mjs`:
  **37/37 files passed**; subject-model checks passed.
- `cd frontend && npm run build`: **1,956 modules transformed**, Vite build
  passed; the pre-existing >500 kB chunk advisory remains.
- Reserved ports 8911, 5174, 8910 and 4173 are stopped.
- Browser/visual/runtime/real-project checks were intentionally not run because
  the authoritative gate is `read_only / blocked`.

## Delegated-Agent Output Review

Not applicable. The source was reviewed directly. The interaction reads only
explicit point fields; it does not infer a risk, source validity, clinical
interpretation or approval from missing data. The existing retained point list
is also keyboard/click reachable, and the first-screen inspector remains closed
until user selection.

## Hermes / Routing Review

Hermes was not dispatched. The workflow guard recorded the Codex direct route;
the current developer instruction and the read-only runtime gate make a
provider or delegated-agent pass unnecessary for this bounded source patch.

## Residual Risk

The inspector is an offline consumer improvement. Real API payload completeness,
source-body delivery, browser ergonomics at target desktop viewports, clinical
accuracy of metric configuration, formal medical review, B6/C14/P8 authority,
independent-AI runs, three-project LOOP and commercial release remain
unverified or blocked. Keep 8911 and all runtime/provider paths stopped.
